BCR-ABL IS(International Scale) Transcript Fusion Quantification by Real time PCR - Blood
New
6,000.00₹
In stock
All over India
0 Reviews
The BCR-ABL IS (International Scale) Transcript Fusion Quantification test is a sensitive molecular assay performed on peripheral blood using real-time reverse transcription-polymerase chain reaction (RT-PCR).
Designed primarily for patients with chronic myeloid leukemia (CML), this test measures the quantity of specific fusion transcripts (such as p210). By standardizing the results onto the International Scale (IS), it allows clinicians to precisely track disease burden, evaluate therapeutic responses to tyrosine kinase inhibitors, and reliably monitor minimal residual disease (MRD) over time across different laboratories with high accuracy and reproducibility.
Designed primarily for patients with chronic myeloid leukemia (CML), this test measures the quantity of specific fusion transcripts (such as p210). By standardizing the results onto the International Scale (IS), it allows clinicians to precisely track disease burden, evaluate therapeutic responses to tyrosine kinase inhibitors, and reliably monitor minimal residual disease (MRD) over time across different laboratories with high accuracy and reproducibility.
The BCR-ABL IS (International Scale) Transcript Fusion Quantification test is a sensitive molecular assay performed on peripheral blood using real-time reverse transcription-polymerase chain reaction (RT-PCR).
Designed primarily for patients with chronic myeloid leukemia (CML), this test measures the quantity of specific fusion transcripts (such as p210). By standardizing the results onto the International Scale (IS), it allows clinicians to precisely track disease burden, evaluate therapeutic responses to tyrosine kinase inhibitors, and reliably monitor minimal residual disease (MRD) over time across different laboratories with high accuracy and reproducibility.
